Zum Hauptinhalt springen

Legal

26. September 2025 | Legal

USA. How Elon Musk’s billionaire Doge lieutenant took over the US’s biggest MDMA company

USA. How Elon Musk’s billionaire Doge lieutenant took over the US’s biggest MDMA company Antonio Gracias is part of the growing movement among Silicon Valley’s right wing enamored with the therapeutic and commercial potential of drugs like MDMA. (T…

29. August 2025 | Legal

USA. Top Democratic senator launches inquiry into for-profit methadone clinics - Probe to examine business practices, treatment of patients at major chains.

USA. Top Democratic senator launches inquiry into for-profit methadone clinics - Probe to examine business practices, treatment of patients at major chains. (…) As an addiction treatment, methadone is only available at roughly 2,000 spec…

23. August 2025 | Legal

USA. It Was a Promising Addiction Treatment. Many Patients Never Got It.

USA. It Was a Promising Addiction Treatment. Many Patients Never Got It. How political red tape and a drug company’s thirst for profits limited the reach of a drug that experts believe could have reduced the opioid epidemic’s toll. (New York Times…

09. August 2025 | Legal

USA/Deutschland. Fight Over Claimed Ownership of Drug-Checking Technology

USA/Deutschland. Fight Over Claimed Ownership of Drug-Checking Technology People have always had to fight for the right to test their drugs, to get information about whether they’re likely to cause a horrendously intense trip, or death. But now, tw…

20. Juli 2025 | Legal

Opioide in Deutschland - Das Geschäft mit den Schmerzen (Podcast)

Opioide in Deutschland - Das Geschäft mit den Schmerzen (Podcast) Tramadol ist eines der am häufigsten verschriebenen Schmerzmittel in Deutschland und wurde zur Partydroge. Warum sieht die zuständige Behörde weg? Der Podcast »Firewall« rekonstruier…

12. Juli 2025 | Legal

Gilead Finalizes Agreement With the Global Fund to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries

Gilead Finalizes Agreement With the Global Fund to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries Strategic Partnership Agreement is Part of Gilead’s…

02. Juli 2025 | Legal

UNAIDS urges Gilead to drop price of new HIV prevention shot

UNAIDS urges Gilead to drop price of new HIV prevention shot GENEVA, 18 June 2025—The United States Food and Drug Administration (FDA) has approved long-acting injectable lenacapavir for HIV prevention. The new medicine is administered by inj…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten